Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
DI Watkins, DR Burton, EG Kallas, JP Moore… - Nature medicine, 2008 - nature.com
Abstract The adenovirus type 5 (Ad5)-based vaccine developed by Merck failed to either
prevent HIV-1 infection or suppress viral load in subsequently infected subjects in the STEP …
prevent HIV-1 infection or suppress viral load in subsequently infected subjects in the STEP …
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo
Genetic diversity plays a key role in human immunodeficiency virus (HIV) adaptation,
providing a mechanism to escape host immune responses and develop resistance to …
providing a mechanism to escape host immune responses and develop resistance to …
Relation between viral fitness and immune escape within the hepatitis C virus protease
J Söderholm, G Ahlen, A Kaul, L Frelin, M Alheim… - Gut, 2006 - gut.bmj.com
Background: The hepatitis C virus (HCV) mutates within human leucocyte antigen (HLA)
class I restricted immunodominant epitopes of the non-structural (NS) 3/4A protease to …
class I restricted immunodominant epitopes of the non-structural (NS) 3/4A protease to …
Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness
L Uebelhoer, JH Han, B Callendret, G Mateu… - PLoS …, 2008 - journals.plos.org
Mechanisms by which hepatitis C virus (HCV) evades cellular immunity to establish
persistence in chronically infected individuals are not clear. Mutations in human leukocyte …
persistence in chronically infected individuals are not clear. Mutations in human leukocyte …
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape
Background Antigen-specific CTL responses are thought to play a central role in
containment of HIV-1 infection, but no consistent correlation has been found between the …
containment of HIV-1 infection, but no consistent correlation has been found between the …
Shear-reversible clusters of HIV-1 in solution: stabilized by antibodies, dispersed by mucin
ABSTRACT HIV-1 has eluded vaccine therapy for the past 40 years. The virus mutates
rapidly and is protected by a shifting glycan shield of mannose sugars, which has hindered …
rapidly and is protected by a shifting glycan shield of mannose sugars, which has hindered …
The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1
Abstract MicroRNAs (miRNAs) are 22-nt non-coding RNAs involved in the regulation of
cellular gene expression and potential cellular defense against viral infection. Using in silico …
cellular gene expression and potential cellular defense against viral infection. Using in silico …
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in Antiretroviral–Treated individuals with drug-resistant human …
Antiretroviral (ARV)–treated patients often maintain low to moderate levels of viremia,
despite the emergence of drug-resistant human immunodeficiency virus (HIV). We studied …
despite the emergence of drug-resistant human immunodeficiency virus (HIV). We studied …
HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge …
Simple Summary DNA immunization with drug-resistant HIV-1 protease (DR PR) is
proposed as immunotherapy to prevent the evolution of HIV-1 towards drug resistance and …
proposed as immunotherapy to prevent the evolution of HIV-1 towards drug resistance and …
Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients
SG Fonseca, A Coutinho-Silva, LAM Fonseca… - Aids, 2006 - journals.lww.com
Objective: To identify promiscuous and potentially protective human CD4 T-cell epitopes in
most conserved regions within the protein-coding genome of HIV-1 clade B consensus …
most conserved regions within the protein-coding genome of HIV-1 clade B consensus …